dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Marx, Gernot |
dc.contributor.author | Zacharowski, Kai |
dc.contributor.author | Ichai, Carole |
dc.contributor.author | Asehnoune, Karim |
dc.contributor.author | Černý, Vladimír |
dc.contributor.author | Dembinski, Rolf |
dc.contributor.author | Ferrer Roca, Ricard |
dc.date.accessioned | 2022-01-13T16:55:41Z |
dc.date.available | 2022-01-13T16:55:41Z |
dc.date.issued | 2021-06-02 |
dc.identifier.citation | Marx G, Zacharowski K, Ichai C, Asehnoune K, Černý V, Dembinski R, et al. Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomiz. Trials. 2021 Jun 2;22:376. |
dc.identifier.issn | 1745-6215 |
dc.identifier.uri | https://hdl.handle.net/11351/6789 |
dc.description | Col·loides; Gelatina; Sèpsia |
dc.description.sponsorship | In this clinical study, B. Braun Melsungen AG, Carl-Braun Str. 1, D-34212 Melsungen acts as the sponsor, funder and data holder of this study. Additionally, it is the manufacturer of IMP, as well as the co-author and medical writer of this manuscript. B. Braun Melsungen AG organized protocol development and contracted a contract research organization (CRO) for clinical trial application, monitoring, and collection/analysis of study data. Investigational tests and reference products will be produced and delivered by B. Braun Melsungen AG to all participating sites. Open Access funding enabled and organized by Projekt DEAL. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Trials;22 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Xoc sèptic - Tractament |
dc.subject | Plasma sanguini |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Sepsis |
dc.subject.mesh | /therapy |
dc.subject.mesh | Plasma Volume |
dc.subject.mesh | Treatment Outcome |
dc.title | Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s13063-021-05311-8 |
dc.subject.decs | sepsis |
dc.subject.decs | /terapia |
dc.subject.decs | volumen plasmático |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1186/s13063-021-05311-8 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Marx G] Klinik für Operative Intensivmedizin und Intermediate Care, Universitätsklinikum RWTH Aachen, 52074 Aachen, Germany. [Zacharowski K] Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Frankfurt/Main, Goethe Universität, 60590 Frankfurt/Main, Germany. [Ichai C] Université Côte d’Azur Service de Réanimation Polyvalente, Hôpital Pasteur 2 – CHU de Nice, 06000 Nice, France. [Asehnoune K] Université de Nantes, CHU – L’Hôtel Dieu, 44093 Nantes Cedex 1, France. [Černý V] Krajská zdravotní, a.s., Masarykova nemocnice v Ústí nad Labem, 401 13 Ústí nad Labem, Czech Republic. [Dembinski R] Klinik für Intensivmedizin und Notfallmedizin, Klinikum Bremen-Mitte, 28177 Bremen, Germany. [Ferrer Roca R] Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34078421 |
dc.identifier.wos | 000660585600001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |